Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

IFNL4 Genotype for Predicting Response to Ledipasvir/Sofosbuvir

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03639207
Recruitment Status : Not yet recruiting
First Posted : August 21, 2018
Last Update Posted : April 22, 2019
Sponsor:
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) )

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Not yet recruiting
  Estimated Primary Completion Date : September 30, 2026
  Estimated Study Completion Date : September 30, 2026